CD28 Superagonistic Activation of T Cells Induces a Tumor Cell-Like Metabolic Program. (2019)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/mab.2018.0042
PubMed Identifier: 31009338
Publication URI: http://europepmc.org/abstract/MED/31009338
Type: Journal Article/Review
Volume: 38
Parent Publication: Monoclonal antibodies in immunodiagnosis and immunotherapy
Issue: 2
ISSN: 2167-9436